ProQR Therapeutics BV (PRQR) Stock Analysis

ProQR Therapeutics BV (PRQR) is a publicly traded company in the HEALTHCARE sector. It trades at $1.47, carries a market capitalization of $149.62M. This page summarizes the public market data, fundamentals, and frequently asked questions for PRQR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.47
• Market Cap: $149.62M
• EPS: $-0.50
• 52-Week High: $3.10
• 52-Week Low: $1.33

Market Sentiment

ProQR Therapeutics BV currently has a Bullish sentiment score of 0.23.

About ProQR Therapeutics BV

ProQR Therapeutics BV, headquartered in Leiden, the Netherlands, is a pioneering biopharmaceutical firm specializing in RNA-based therapies for severe genetic disorders. The company boasts a robust pipeline, featuring advanced candidates targeting both rare and prevalent diseases, and utilizes its proprietary technology platform to develop innovative solutions that tackle the root causes of these conditions. With a strong commitment to cutting-edge research and development, ProQR is positione...

GNG Research Analysis

GNG Research scores ProQR Therapeutics BV (PRQR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PRQR.

Frequently Asked Questions

Does PRQR pay dividends?

ProQR Therapeutics BV (PRQR) does not currently pay a regular dividend.

What is PRQR's market cap?

ProQR Therapeutics BV (PRQR) has a market capitalization of $149.62M with a current stock price of $1.47.